SM
AUPH icon

Sabby Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Sabby Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-85,625
Closed -$1.09M – 166
2021
Q1 		$1.11M Buy
85,625
+29,682
+53% +$431K 0.22% 76
2020
Q4 		$774K Buy
55,943
+42,399
+313% +$617K 0.15% 54
2020
Q3 		$200K Sell
13,544
-11,456
-46% -$166K 0.03% 98
2020
Q2 		$406K Sell
25,000
-17,500
-41% -$280K 0.08% 62
2020
Q1 		$617K Buy
+42,500
New +$750K 0.26% 36

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Sabby Management's AUPH Position: Q2 2021 in Review

Sabby Management sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2021, closing a stake of 85,625 shares — an estimated $1.09M sold.

Sabby Management first reported a position in AUPH in Q1 2020 and held it in 5 quarters. The position peaked at $1.11M in Q1 2021. 167 funds tracked by Wall St. Rank hold AUPH as of Q2 2021.

  • Sabby Management reported no remaining Aurinia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sabby Management sold 85,625 Aurinia Pharmaceuticals shares in Q2 2021, an estimated $1.09M.
  • Sabby Management first reported a position in Aurinia Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • Sabby Management's Aurinia Pharmaceuticals position peaked at $1.11M in Q1 2021.
  • 167 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2021.

Based on Sabby Management's 13F filing for Q2 2021, filed 16 Aug 2021.